MEDICIS PHARMACEUTICAL CORP (MRX) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 345 transactions totaling $59.3M, demonstrating a bearish sentiment with -$58.8M in net insider flow. The most recent transaction on Dec 11, 2012 involved a transaction of 8,497 shares valued at $373.9K.
No significant insider buying has been recorded for MRX in the recent period.
No significant insider selling has been recorded for MRX in the recent period.
Based on recent SEC filings, insider sentiment for MRX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$58.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at MEDICIS PHARMACEUTICAL CORP (MRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading MRX stock, having executed 345 transactions in the past 90 days. The most active insider is Jonah Shacknai (Executive), who has made 39 transactions totaling $100.3M.
Get notified when executives and directors at MRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 11, 2012 | G. Altschul Arthur Jr | Executive | Disposition | 8,497 | $44.00 | $373.9K | |
| Dec 11, 2012 | G. Altschul Arthur Jr | Executive | Disposition | 8,497 | $44.00 | $373.9K | |
| Dec 11, 2012 | Davidson Spencer | Executive | Disposition | 9,722 | $44.00 | $427.8K | |
| Dec 11, 2012 | Diamond Stuart | Executive | Disposition | 8,674.67 | $44.00 | $381.7K | |
| Dec 11, 2012 | S. Knight Peter | Executive | Disposition | 12,532 | $44.00 | $551.4K | Large |
| Dec 11, 2012 | Pietrangelo Michael | Executive | Disposition | 15,920 | $44.00 | $700.5K | Large |
| Dec 11, 2012 | S. Schein Philip | Executive | Disposition | 8,222 | $44.00 | $361.8K | |
| Dec 11, 2012 | H. Shackelford Lottie | Executive | Disposition | 10,422 | $44.00 | $458.6K | |
| Dec 11, 2012 | Shacknai Jonah | Executive | Disposition | 928,825 | $44.00 | $40.9M | Large |
| Dec 11, 2012 | A. Prygocki Mark Sr | Executive | Disposition | 301,613 | $44.00 | $13.3M | Large |
| Dec 11, 2012 | A. Prygocki Mark Sr | Executive | Disposition | 552 | $44.00 | $24.3K | |
| Dec 11, 2012 | S. Wortzman Mitchell | Executive | Disposition | 718 | $44.00 | $31.6K | |
| Dec 11, 2012 | S. Wortzman Mitchell | Executive | Disposition | 203,990 | $44.00 | $9.0M | Large |
| Dec 11, 2012 | D. Peterson Richard | Executive | Disposition | 102 | $44.00 | $4.5K | |
| Dec 11, 2012 | D. Peterson Richard | Executive | Disposition | 205,889 | $44.00 | $9.1M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 18 | $96.4M | 42.5% |
Sale(S) | 60 | $59.1M | 26.0% |
Exercise(M) | 50 | $39.9M | 17.6% |
Payment(F) | 135 | $31.2M | 13.8% |
Purchase(P) | 3 | $223.2K | 0.1% |
Gift(G) | 9 | $64.6K | 0.0% |
Small Acquisition(L) | 11 | $2.2K | 0.0% |
Award(A) | 59 | $0 | 0.0% |
Insider selling pressure at MEDICIS PHARMACEUTICAL CORP has increased, with 16 insiders executing 345 transactions across all time. Total sales of $59.1M significantly outpace purchases of $223.2K, resulting in a net outflow of $58.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.